Novel peptidoglycan-based diagnostic devices for detection of wound infection

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 1, 2011, Pages 12-23

  Hasmann, Andrea ^a   Wehrschuetz Sigl, Eva ^b   Kanzler, Gertraud ^a   Gewessler, Ulrike ^a   Hulla, Elisabeth ^b   Schneider, Konstantin P ^b   Binder, Barbara ^c   Schintler, Michael ^c   Guebitz, Georg M ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Diagnosis; Elastase; Infection; Lysozyme; Wound

Indexed keywords

AGAROSE; ALGINIC ACID; BRILLIANT BLUE; DYE; ELASTASE; GELATINASE A; GELATINASE B; LYSOZYME; PEPTIDOGLYCAN; PROTEINASE;

ARTICLE; CONTROLLED STUDY; DECUBITUS; DIAGNOSTIC TEST; ENZYME ACTIVITY; HUMAN; HYDROLYSIS; INCUBATION TEMPERATURE; INCUBATION TIME; PRIORITY JOURNAL; SURGICAL WOUND; WESTERN BLOTTING; WOUND FLUID; WOUND INFECTION;

BODY FLUIDS; CLINICAL ENZYME TESTS; COLORING AGENTS; GELATINASES; HUMANS; MURAMIDASE; PEPTIDE HYDROLASES; PEPTIDOGLYCAN; WOUND INFECTION;

EID: 80051666036     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.09.009     Document Type: Article

References (45)

1. Barrick B., Campbell E.J., Owen C.A. Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes. Wound Repair Regen. 1999, 7:410-422.
2. Callam M.J., Ruckley C.V., Harper D.R., Dale J.J. Chronic ulceration of the leg-extent of the problem and provision of care. Br. Med. J. 1985, 290:1855-1856.
3. Cao L., Xie L., Xue X., Tan H., Liu Y., Zhou S. Purification and characterization of alginate lyase from Streptomyces species strain A5 isolated from banana rhizosphere. J. Agric. Food Chem. 2007, 55:5113-5117.
4. Carlsson J., Malmqvist M. Effects of bacterial agarase on agarose gel in cell culture. In Vitro Cell Dev-Pl 1977, 13:417-422.
5. Clark R.A.F. The Molecular and Cellular Biology of wound Repair 1996, Springer, US.
6. Collier M. Recognition and management of wound infections. World Wide Wounds 2004.
7. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 2004, 9:283-289.
8. Ghuysen J.M., Tipper D.J., Strominger J.L. Enzymes that degrade bacterial cell walls. Method Enzymol. 1966, 8:685-699.
9. Goodman A.L., Kulasekara B., Rietsch A., Boyd D., Smith R.S., Lory S. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev. Cell. 2004, 7:745-754.
10. Gronhagen-Riska C., Selroos O. Angiotensin converting enzyme. IV. Changes in serum activity and in lysozyme concentrations as indicators of the course of untreated sarcoidosis. Scand. J. Respir. Dis. 1979, 60:337-344.
11. Haneberg B., Glette J., Talstad I., Sornes S., Solberg C.O. In vitro release of lysozyme from monocytes and granulocytes. J. Leukocyte. Biol. 1984, 35:573-582.
12. Hardt M., Guo Y., Henderson G., Laine R.A. Zymogram with Remazol brilliant blue-labeled Micrococcus lysodeikticus cells for the detection of lysozymes: example of a new lysozyme activity in Formosan termite defense secretions. Anal. Biochem. 2003, 312:73-76.
13. Hart J. Inflammation. 1: its role in the healing of acute wounds. J. Wound Care 2002, 11:205-209.
14. Hassairi I., Ben Amar R., Nonus M., Gupta B.B. Production and separation of alpha-agarase from Altermonas agarlyticus strain GJ1B. Bioresour. Technol. 2001, 79:47-51.
15. Hayward P., Hokanson J., Heggers J., Fiddes J., Klingbeil C., Goeger M., Robson M. Fibroblast growth-factor reverses the bacterial retardation of wound contraction. Am. J. Surg. 1992, 163:288-293.
16. Ito Y., Yamada H., Imoto T. Colorimetric assay for lysozyme using Micrococcus luteus labelled with a blue dye, Remazol brilliant blue R, as a substrate. Chem. Pharm. Bull. 1992, 40:1523-1526.
17. Jones S.G., Edwards R., Thomas D.W. Inflammation and wound healing: the role of bacteria in the immuno-regulation of wound healing. Int. J. Low. Extrem. Wounds 2004, 3:201-208.
18. Krasner D. Chronic Wound Care: a clinical source book for professionals 1997, Health Management Publications Inc, Wayne, PA, 1997. D. Krasner, G. Rodeheaver, R.G. Sibbald (Eds.).
19. Malmqvist M. Degradation of agarose gels and solutions by bacterial agarase. Carbohydr. Res. 1978, 62:337-348.
20. Mani R. Science of measurements in wound healing. Wound Repair Regen. 1999, 7:330-334.
21. Nelzen O., Bergqvist D., Lindhagen A., Hallbook T. Chronic leg ulcers-an underestimated problem in primary health-care among elderly patients. J. Epidemiol. Community Health 1991, 45:184-187.
22. Osserman E.F., Klockars M., Halper J., Fischel R.E. Effects of lysozyme on normal and transformed mammalian-cells. Nature 1973, 243:331-335.
23. Osserman E.F., Lawlor D.P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Exp. Med. 1966, 124:921-952.
24. Pascual R.S., Gee J.B.L., Finch S.C. Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis. N. Engl. J. Med. 1973, 289:1074-1076.
25. Pricelius S., Murkovic M., Souter P., Guebitz G.M. Substrate specificities of glycosidases from Aspergillus species pectinase preparations on elderberry anthocyanins. J. Agric. Food Chem. 2009, 57:1006-1012.
26. Robson M.C. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg. Clin. North Am. 1997, 77:637-650.
27. Salton M.R. Anatomy of bacterial surface. Bacteriol. Rev. 1961, 27:77-99.
28. Sawabe T., Ohtsuka M., Ezura Y. Novel alginate lyases from marine bacterium Alteromonas sp. strain H-4. Carbohydr. Res. 1997, 304:69-76.
29. Selroos O., Klockars M. Serum lysozyme in sarcoidosis - evaluation of its usefulness in determination of disease activity. Scand. J. Respir. Dis. 1977, 58:110-116.
30. Shockman G.D., Höltje J.V. Chapter 7 Microbial peptidoglycan (murein) hydrolases. New Comprehensive Biochemistry 1994, 131-166.
31. Shugar D. The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme. Biochim. Biophys. Acta. 1952, 8:302-309.
32. Stadelmann W.K., Digenis A.G., Tobin G.R. Impediments to wound healing. Am. J. Surg. 1998, 176:39S-47S.
33. Stenberg B.D., Phillips L.G., Hokanson J.A., Heggers J.P., Robson M.C. Effect of bFGF on the inhibition of contraction caused by bacteria. J. Surg. Res. 1991, 50:47-50.
34. Sylvia C.J. The role of neutrophil apoptosis in influencing tissue repair. J. Wound Care 2003, 12:13-16.
35. Tomita H., Sato S., Matsuda R., Sugiura Y., Kawaguchi H., Niimi T., Yoshida S., Morishita M. Serum lysozyme levels and clinical features of sarcoidosis. Lung 1999, 177:161-167.
36. Torsteinsdottir I., Hakansson L., Hallgren R., Gudbjornsson E., Arvidson N.G., Venge P. Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology 1999, 38:1249-1254.
37. Trengove N.J., Langton S.R., Stacey M.C. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen. 2002, 4:234-239.
38. Trengove N.J., Stacey M.C., Macauley S., Bennett N., Gibson J., Burslem F., Murphy G., Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999, 7:442-452.
39. Tschaikowsky K., Sittl R., Braun G.G., Hering W., Rugheimer E. Increased Fmet-Leu-Phe receptor expression and altered superoxide production of neutrophil granulocytes in septic and posttraumatic patients. Clin. Investig. 1993, 72:18-25.
40. Turton C.W.G., Grundy E., Firth G., Mitchell D., Rigden B.G., Turner-Warwick M. Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax 1979, 34:57-62.
41. Wang Y.Y., Myhre A.E., Pettersen S.J., Dahle M.K., Foster S.J., Thiemermann C., Bjørnland K., Aasen A.O., Wang J.E. Peptidoglycan of Staphylococcus aureus induces enhanced levels of matrix metalloproteinase-9 in human blood originating from neutrophils. Shock 2005, 24:214-218.
42. Wong T.Y., Preston L.A., Schiller N.L. ALGINATE LYASE: review of major sources and enzyme characteristics, structure-function analysis, biological roles, and applications. Annu. Rev. Microbiol. 2000, 54:289-340.
43. Wysocki A.B., Staiano-Coico L., Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Investig. Dermatol. 1993, 101:64-68.
44. Yager D.R., Kulina R.A., Gilman L.A. Wound fluids: a window into the wound environment?. Int. J. Low. Extrem. Wounds 2007, 6:262-272.
45. Yager D.R., Nwomeh B.C. The proteolytic environment of chronic wounds. Wound Repair Regen. 1999, 7:433-441.